Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma
- Trial number:
- NCT02633514
- Trial phase:
- 3
- Study type:
- Local/Regional therapies, Chemotherapy
- Overall status:
- Recruiting
Study start date
December, 2023
Scientific title
A Randomized Phase III Study of Adjuvant Radiotherapy Versus Adjuvant Radiochemotherapy in Patients With Incomplete ResectionThymoma or Thymic Carcinoma
Summary
This study is designed to investigate whether adjuvant radiochemotherapy after incomplete resection has a better survival than adjuvant radiotherapy for thymoma or thymic carcinoma.
18~75 years old; Eastern Cooperative Oncology Group performance status of 0 to 2; Pathologically confirmed ; incomplete resection (R1 or R2);have adequate bone marrow, hepatic, and renal function;Patients receive incomplete resection within 3 months; Written informed consent.
Study design
Primary purpose:
Treatment, Allocation:
Randomized, Intervention model:
Parallel Assignment, Masking:
None (Open Label),
Conditions
Thymoma and Thymic Carcinoma
Other study ID numbers
1508151-6
Choose trial site (1)
Kailiang Wu
Shanghai, China